The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Non-invasive Prenatal Testing Market During The Forecast Period?
The non-invasive prenatal testing market has witnessed rapid growth in recent years. Its valuation is set to increase from $6.27 billion in 2025 to $7.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. Key factors contributing to its historical expansion include heightened awareness of prenatal screening, a shift from invasive diagnostic methods, the rising utilization of assay kits and reagents, the adoption of next-generation sequencing in laboratories, and the demand for early identification of chromosomal abnormalities.
The non-invasive prenatal testing market is projected for substantial expansion over the coming years, with its size anticipated to reach $12.37 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 14.4%. This anticipated growth during the forecast period is fueled by several factors, including the increasing global embrace of non-invasive prenatal testing, greater investment in sophisticated sequencing technologies, the expansion of hospital and diagnostic laboratory infrastructures, a surging demand for early genetic screening, and the progressive integration of AI and data analytics into prenatal diagnostic methods. Key trends expected during this period encompass the growing adoption of AI-based genetic analysis, the more widespread application of NGS and PCR systems for prenatal testing, an increase in the deployment of cloud-based data management solutions in diagnostics, the broader implementation of high-throughput screening technologies, and the further integration of personalized prenatal risk assessment.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp
Which Strong Drivers Are Impacting The Non-invasive Prenatal Testing Market Growth?
The future expansion of the non-invasive prenatal testing market is anticipated to be fueled by the rising age of mothers. This trend of older maternal age results from various factors, including the pursuit of education and careers, achieving financial stability, personal preferences, later marriages, advancements in contraception, and broader societal shifts, all of which empower women to make deliberate choices regarding family planning. When women postpone having children, the likelihood of chromosomal abnormalities increases, leading more pregnant individuals to choose non-invasive prenatal testing (NIPT) for evaluating their pregnancy’s health. As an illustration, in March 2025, the Centers for Disease Control and Prevention, a US government organization, reported that in 2023, the average age for mothers having their first child climbed to 27.5 years, an increase from 27.4 in 2022, establishing a new national record. Consequently, the steady rise in maternal age will consistently drive the expansion of the non-invasive prenatal testing market.
What Are The Main Segments Within The Non-invasive Prenatal Testing Market Segment Structure?
The non-invasive prenatal testing market covered in this report is segmented –
1) By Type: Consumables, Instruments
2) By Application: Trisomy, Microdeletion, Genetics, Rh factor
3) By End User: Hospital, Diagnostic Labs
Subsegments:
1) By Consumables: Assay Kits, Reagents, Disposables
2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices
Which Trends Are Contributing To Changes In The Non-invasive Prenatal Testing Market?
Leading companies operating in the non-invasive prenatal testing (NIPT) market are concentrating on developing advanced solutions, such as linked-SNP (single nucleotide polymorphism) technology, to enhance diagnostic precision, improve the detection of complex genetic cases, and minimize reliance on paternal samples. This linked-SNP technology evaluates single-gene variants by analyzing genetically linked markers across the genome to infer inheritance patterns, thereby enabling more accurate identification of challenging conditions like homozygous mutations. For instance, in August 2025, Natera, a US-based cell-free DNA (cfDNA) testing and precision medicine company, launched Fetal Focus, a NIPT for inherited single-gene disorders that directly screens the fetus using only maternal blood when the biological father is unavailable. The test targets five genes: CFTR, SMN1, HBA1/HBA2, and HBB, and is supported by data from the EXPAND clinical trial. In its first readout (n=101), Fetal Focus demonstrated 91% sensitivity and successfully detected all five homozygous variant fetuses, underscoring the strength of its linked-SNP-based approach in delivering noninvasive and clinically meaningful risk assessment.
Who Are The Companies Participating In The Non-invasive Prenatal Testing Market?
Major companies operating in the non-invasive prenatal testing market are F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc., Beijing Genomics Institute
Get The Full Non-invasive Prenatal Testing Market Report:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Which Region Dominates The Non-invasive Prenatal Testing Market By Market Share?
North America was the largest region in the non-invasive prenatal testing market in 2025. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Non-invasive Prenatal Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Browse Through More Reports Similar to the Global Non-invasive Prenatal Testing Market 2026, By The Business Research Company
Non Injectable Insulin Market Report 2026
https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report
Oem Insulation Market Report
https://www.thebusinessresearchcompany.com/report/oem-insulation-global-market-report
Antidiabetics Market Report
https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model